Register Login

ARS PHARMACEUTICALS, INC. (SPRY)

Smith Margaret Ekins 🟢 acquired 1.0M shares (1 derivative) of ARS Pharmaceuticals, Inc. (SPRY) at $5.77 ($5.8M) Transaction Date: Sep 01, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot Sept. 2, 2026, 9:28 p.m.

    🔍 Smith Margaret Ekins (Executive)

    Company: ARS Pharmaceuticals, Inc. (SPRY)

    Report Date: 2026-09-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,001,738

    Detailed Transactions and Holdings:

    • Acquired 1,001,738 shares of Stock Option (right to buy) at $5.77 per share (Derivative)
      Date: 2026-09-01 | Code: A | Expires: 2036-08-31 | equity_swap_involved: 0 | shares_owned_after: 1,001,738.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 25% of the shares subject to the option vest on August 17, 2027, and the remaining shares will vest monthly thereafter over three years.

Search

News categories